NightHawk Biosciences : Management's Discussion and Analysis of Financial Condition and Results of Operations with Retrospective Changes of the 2022 Form 10-K - Form 8-K -December 19, 2023 at 04:11 pm EST

Management's Discussion and Analysis of Financial Condition and Results of Operations with Retrospective Changes of the 2022 Form 10-K.


The following discussion...

Related Keywords

Texas ,United States ,Canada ,New Market ,North Carolina ,Raleigh ,Parsippany ,New Jersey ,United Kingdom ,Kansas ,Morrisville ,Michigan ,San Antonio ,Japan ,Delaware ,New Brunswick ,State Of Kansas ,America ,Biologics Gmb ,Jeffrey Wolf ,Monte Carlo ,William Ostrander ,Jeff Wolf ,Pelican Therapeutics Inc ,European Union ,Deposit Insurance Corporation ,Delphi Therapeutics Inc ,Heat Biologics Ii Inc ,Research Institute Of Texas ,National Institute Of Allergy ,Heat Biologicsi Inc ,Valuation Of Developed Technology ,University Of Miami ,Company At ,Us Strategic National Stockpile ,Elusys Holdings Inc ,University Of Michigan ,Heat Biologics Iv Inc ,Nighthawk Biosciences Inc ,Party Transactions ,Blackhawk Bio Inc ,B Riley Fbr Inc ,Scorpion Biological Services Inc ,Development Authority ,Biomedical Advanced Research ,Public Company Accounting Oversight Board United States ,Public Accounting Firm ,Department Of Defense Do ,Elusys Therapeutics Inc ,Elusys Therapeutics ,Scorpius Biomanufacturing Inc ,Merchant Ice ,National Institutes Of Health ,Abacus Biotech Inc ,Merchants Ice ,Exchange Commission ,Company Overview ,Heat Biologics Iii Inc ,Skunkworx Bio Inc ,Zolovax Inc ,Heati Inc ,Compensation Committee Of The Board Directors ,Heat Biologics Australia Pty Ltd ,Cantor Fitzgerald Co ,University Of Miami Heat Biologicsi Inc ,Shattuck Labs Inc ,Government Services Of Canada ,Heat Biologics Inc ,Compensation Committee ,Financial Condition ,Retrospective Changes ,Elusys Business ,Current Good Manufacturing Practices ,Scorpius Biomanufacturing ,National Institute ,Infectious Disease ,National Stockpile ,Public Health Agency ,Canada Office ,Emergency Response Services ,Deferred Revenue ,Intangible Assets ,Income Taxes ,Development Costs ,Ended December ,Financing Lease ,Future Financing Needs ,Restated Common Stock Sales Agreement ,Cantor Fitzgerald ,Qualitative Disclosures About Market Risk ,Supplemental Data ,Independent Registered Public Accounting Firm ,Consolidated Financial ,Independent Registered Public Accounting ,Nighthawk Biosciences ,Public Company Accounting Oversight Board ,Elusys Earn ,Impairment Testing ,Stockholder Equity ,Hawk Biosciences ,Consolidated Financial Statements ,Cash Equivalents ,Cash Flow Information ,Skunkworx Bio ,Heat Biologics ,Third Amended ,Restated Certificate ,Significant Accounting ,Pelican Therapeutics ,Heat Biologics Gmbh ,Delphi Therapeutics ,Scorpion Biological Services ,Blackhawk Bio ,Abacus Biotech ,Accepted Accounting Principles ,Discontinued Operations ,Accounting Standards Codification ,Condensed Consolidated Financial Statements ,Prior Quarterly ,Staff Accounting Bulletin ,Prior Year Misstatements ,Quantifying Misstatements ,Current Year Financial Statements ,Interim Financial ,Good Manufacturing Practices ,Federal Deposit Insurance Corporation ,New Market Tax Credit ,Loss Attributable ,Non Controlling Interests ,Shattuck Labs ,Cancer Prevention ,Research Institute ,Accounting Standards Update ,Not For Profit Entities ,Accounting Guidance ,Contributions Received ,Contributions Made ,Infectious Diseases ,National Institutes ,Financial Statements ,Recently Issued Accounting Standards ,Term Investments ,Financial Instruments ,Merger Agreement ,Merger Consideration ,Closing Date ,Business Combinations ,License Agreements ,License Agreement ,Biologics License Application ,New Drug Application ,Heat Shock Proteins Antigenic Peptide ,Exclusive License Agreement ,Licensed Products ,Licensed Product ,Public Works ,Government Services ,Grant Contract ,Preferred Stock ,Common Stock Sales Agreement ,Incentive Plan ,Option Plan ,Stock Incentive Plan ,Chief Executive Officer ,Chief Financial Officer ,Stock Option Plan ,Stock Based Compensation ,Compensation Expense ,Operating Losses ,Taxable Income ,North Carolina General Assembly ,Senate Bill ,Internal Revenue Code ,North Brunswick ,Year Ended December ,Loss Per ,Financial Data ,Three Months Ended June ,Six Months Ended June ,Three Months Ended September ,Nine Months Ended September ,Six Months Ended ,Nine Months Ended ,Consolidated Balance Sheets ,Purchase Agreement ,Equity Interests Purchase Agreement ,Elusys Holdings ,Markets ,